Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

14.31 -0.20 (-1.38%)
Official Closing Price Updated: 7:00 PM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
What's going on in today's session: S&P500 most active stocks
Looking for the most active stocks in the S&P500 index on Wednesday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market. 
Via Chartmill
Nvidia To Rally Around 37%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
This Stride Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
 
Via Benzinga
Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety
Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women. 
Via Benzinga
Topics Lawsuit
Looking Into Kenvue Inc's Recent Short Interest
 
Via Benzinga
Kenvue Stock Climbs Premarket, Day After Record Slide On UK Lawsuit: Retail Bulls Remain Unshaken
Via Stocktwits
Kenvue Stock Drops After Texas Attorney General Sues Company Alleging Deceptive Marketing Of Tylenol
The lawsuit comes on the heels of President Trump linking Tylenol to autism. 
Via Stocktwits
Topics Government Lawsuit
Renaissance Capital Opens New Circle Internet Group (NASDAQ: CRCL) Position: Is the New IPO a Buy?
Renaissance Capital Opens New Circle Internet Group (NASDAQ: CRCL) Position: Is the New IPO a Buy? 
Via The Motley Fool
Topics Initial Public Offering
Renaissance Capital Bets Big on Tylenol and Kenvue (KVUE) By Purchasing Over 351,000 Shares
Renaissance Capital Bets Big on Tylenol and Kenvue (KVUE) By Purchasing Over 351,000 Shares 
Via The Motley Fool
3 Healthcare Stocks Paying the Highest Dividends of 2025
If you are looking for high yields in the healthcare sector, here are three choices. Make sure you understand the risks before you buy them. 
Via The Motley Fool
Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever.
Looking at high-yield healthcare stocks? These three stand out (but one has a slight skew to its story). 
Via The Motley Fool
Topics Government
Renaissance Capital Sells Off 176K CRBG Shares Worth $6.3 Million
Via The Motley Fool
Topics Regulatory Compliance Retirement
These S&P500 stocks are gapping in today's session
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Monday. Discover the gap up and gap down stocks in the S&P500 index. 
Via Chartmill
3 Dividend Stocks With 5% (or Higher) Yields to Buy Hand Over Fist in October
These three stocks have elevated yields and attractive dividend histories. 
Via The Motley Fool
Meet the 5%-Yielding Dividend Stock That Could Soar in 2026
Kenvue could start to recover in 2026. 
Via The Motley Fool
Johnson & Johnson's M&A Strategy Is the Real Story for Investors
Johnson & Johnson’s rumored Protagonist buyout demonstrates its proven M&A strategy: divesting low-growth units to fund high-margin, innovative assets. 
Via MarketBeat
Uncover the latest developments among S&P500 stocks in today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday. 
Via Chartmill
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session.
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
Which S&P500 stocks are moving on Friday?
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday. 
Via Chartmill
Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
Why Kenvue Stock Tumbled by 13% on Thursday
The company's baby powder product is under legal fire once again. 
Via The Motley Fool
Topics Lawsuit
Kenvue's Dual Dilemma: Tylenol and Talc Fears Trigger Sector Jitters
New York, NY – October 16, 2025 – The Consumer Staples and Healthcare sectors of the S&P 500 are experiencing a notable day of underperformance, largely overshadowed by the precipitous stock plunge of... 
Via MarketMinute
Topics Death Government Lawsuit
Johnson & Johnson Plunges Amidst Escalating Talc Litigation: Billions at Stake as Legal Battles Intensify
New York, NY – October 16, 2025 – Johnson & Johnson (NYSE: JNJ), once considered a stalwart of stability, is currently navigating turbulent waters, finding itself among the market's bottom performers... 
Via MarketMinute
Topics Bankruptcy Death Lawsuit
Kenvue (KVUE) Plunges Amidst Dual Headwinds: Tylenol Fears and Escalating Talc Litigation
Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has found itself at the bottom of today's market performance, with its stock price experiencing a significant decline. As... 
Via MarketMinute
Topics Government Lawsuit
Discover which S&P500 stocks are making waves on Thursday.
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday. 
Via Chartmill
These S&P500 stocks are the most active in today's session
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
What's going on in today's session: S&P500 movers
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. 
Via Chartmill
Johnson & Johnson, Kenvue Named In First Ever UK Legal Action Over Talc Cancer Claims
Johnson & Johnson faces 3,000 UK lawsuits alleging asbestos-contaminated talcum powder caused cancer and concealed risks for decades. 
Via Benzinga
Topics Lawsuit
Johnson & Johnson Battles New UK Talc Cancer Claims Worth £1B After Massive US Verdict: Report
Meanwhile, analysts raised price targets on the stock following strong Q3 results and the planned orthopedic spin-off. 
Via Stocktwits
Topics Bankruptcy Death Lawsuit
2 Ultra-High-Yield Dividend Stocks With Total Return Potential of Up to 41% in 12 Months, According to Select Wall Street Analysts
Juicy dividends are only part of the attraction with these beaten-down stocks. 
Via The Motley Fool
Topics Government
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.